Pacira Pharmaceuticals Stock Forecast

Buy or Hold candidate since Jun 26, 2026 Gain 2.54%

The Pacira Pharmaceuticals stock price fell by -0.193% on the last day (Friday, 24th Jul 2026) from $25.93 to $25.88. During the last trading day the stock fluctuated 2.56% from a day low at $25.38 to a day high of $26.03. The price has risen in 6 of the last 10 days and is up by 1.57% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -390 thousand shares and in total, 409 thousand shares were bought and sold for approximately $10.60 million.

The stock lies in the upper part of a wide and weak rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $25.96 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 8.09% during the next 3 months and, with a 90% probability hold a price between $25.29 and $28.06 at the end of this 3-month period.

PCRX Signals & Forecast

The Pacira Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $25.68 and $24.46. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 23, 2026, and so far it has fallen -0.193%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Pacira Pharmaceuticals stock

Pacira Pharmaceuticals finds support from accumulated volume at $25.49 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.650 between high and low, or 2.56%. For the last week the stock has had daily average volatility of 3.05%.

Our recommended stop-loss: $24.85 (-3.97%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (PCRX) For The Upcoming Trading Day Of Monday 27th

For the upcoming trading day on Monday, 27th we expect Pacira Pharmaceuticals to open at $25.76, and during the day (based on 14 day Average True Range), to move between $25.45 and $26.31, which gives a possible trading interval of +/-$0.85 (+/-3.36%) up or down from last closing price. If Pacira Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 3.36% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $25.93 (0.19%) than the support at $25.49 (1.51%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Pacira Pharmaceuticals stock A Buy?

Pacira Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.712 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 27, 2026 - $25.76 ( 0.451%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk